Company intelligence / Profile preview
PrimeGenX Therapeutics
- Ownership
- Private
- Development stage
- Other
Overview
PrimeGenX is a biotechnology company specializing in regenerative medicine and stem cell research. The company is best known for its proprietary PrimeCell technology, which focuses on identifying and reprogramming adult germline-derived stem cells into pluripotent-like states. This approach aims to provide the therapeutic benefits of embryonic stem cells without the associated ethical or legal complications. Based in Irvine, California, PrimeGenX targets a wide range of applications, including organ repair, anti-aging, and the treatment of chronic degenerative conditions. The company's research efforts are centered on harnessing the natural regenerative potential of adult cells to address unmet medical needs.
- Therapeutic areas
- NephrologyNeurologyOther
- Modalities
- Stem cell therapyCell therapy
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on PrimeGenX Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PrimeGenX Therapeutics.